الفهرس 
Introduction and Aim of the WorkOnly 14 pages are availabe for public view
 |  | from | 181 |  |  |
| | | from | 181 | | |
Abstract
The aim of the work is to evaluate whether early insulin therapy in recently diagnosed type 2 diabetics in advantageous compared with oral hypoglycemic drugs.
Conclusions:
1- Continued attention to lifestyle modification should be encouraged at every step of diabetes intervention.
2- The usual slow transition from one regimen of therapy with OHD to the next, without achieving adequate control, should be avoided.
3- The concept of insulin as expected therapy in the management of type 2 diabetes should be introduced on diagnosis, whether or not the patient’s blood glucose levels at the time can be adequately controlled by other means. Better adherence and more successful outcomes will result when the false idea that insulin therapy is a sign of failure or worsening disease is permanently dispelled.
4- Short-term invasive therapy even from disease onset can preserve β-cell function and, thus, insulin secretion, allowing long-term glycemic control without medication and may improve glycemic responses to supplemental oral treatment if needed.
5- Physicians must, therefore, view insulin as a vital therapeutic tool for attaining and sustaining treatment goals, not as a sign of treatment failure.